June 6, 2025PFIZER INC. PFE Partners with Acepodia, Innovating Cancer Treatments ~1 min.Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....
April 4, 2025PFIZER INC. Hits Forecast Price Target with 7.0% Profit - QuantWave Analysis ~1 min.PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....
April 3, 2025PFIZER INC. Hits Price Target Forecast with 7.05% Profit ~1 min.QuantWave's forecast for PFIZER INC. proved to be successful as the stock reached the predicted target price of 23.84 $ on April 3, 2025, from the initial signal date of May 7, 2024, when the price was at 25....
March 27, 2025With 67 ownership Pfizer Inc. NYSE:PFE boasts of strong institutional backing ~1 min.Pfizer Inc., a renowned pharmaceutical company, is currently enjoying the support of strong institutional investors with a significant 67% ownership....
March 21, 2025Analyst Says Pfizer PFE Stock Will Move Too Fast to Catch ~1 min.According to recent analysis by Stocks Prognosis, Pfizer Inc. (NYSE:PFE) is expected to experience significant movement in its stock price in the near future....
January 7, 2025The Home Depot Inc. Sees Increase in Pensionfund Sabic's Stake ~1 min.Pensionfund Sabic has recently grown its stake in The Home Depot Inc., according to reports....
January 10, 2025UnitedHealth Group Incorporated Faces Investor Pressure to Review Insurance Practices ~1 min.Following recent criticism from investors, UnitedHealth Group Incorporated (NYSE:UNH) is under pressure to review its insurance practices....
March 19, 2025Investing in Vertex Pharmaceuticals: A Lucrative Opportunity for Biotech Enthusiasts ~2 min.Vertex Pharmaceuticals Incorporated (VRTX) has emerged as one of the most promising biotech stocks in the market, attracting the attention of top investors....
January 22, 2025Regeneron Pharmaceuticals REGN Faces Securities Class Action After Losing 9 Billion Value Following Q3 2024 Earnings Report ~1 min.Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is facing a securities class action after suffering a massive value loss of 9 billion following their Q3 2024 earnings report....
January 9, 2025UnitedHealth Group Incorporated's Fundamentals Good Enough Despite Recent Weakness ~1 min.UnitedHealth Group Incorporated (NYSE:UNH) is a leading healthcare company that has been experiencing a recent dip in its stock performance....
